Please login to the form below
infectious diseases
This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.
J&J could launch its single-dose COVID-19 vaccine in March
of Allergy and Infectious Diseases (NIAID).
Latest news
-
Sinovac’s COVID-19 vaccine demonstrates 50.4% efficacy in Brazilian trial data
The results from phase 1 and phase 2 trials, published in The Lancet Infectious Diseases, evaluated the CoronaVac vaccine in over 700 participants.
-
CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
potential infection due to viral exposure," said Lidia Oostvogels, head of infectious diseases of CureVac.
-
J&J completes enrolment for late-stage COVID-19 vaccine trial
The phase 3 ENSEMBLE trial is being conducted in collaboration with the US Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID).
-
FDA briefing document paves the way for Pfizer/BioNTech COVID-19 vaccine approval
Following the approval, the director of the US National Institute of Allergy and Infectious Diseases (NIAID) Dr Anthony Fauci initially commented that the UK’s approval process for the vaccine had
-
NIAID chief back-pedals on criticism of UK's Pfizer vaccine approval process
Anthony Fauci apologised for previous comments in BBC interview. The director of the US National Institute of Allergy and Infectious Diseases (NIAID) Dr Anthony Fauci (pictured above) has apologised after previously
More from news
Approximately 4 fully matching, plus 220 partially matching documents found.
Latest Intelligence
-
The pandemic preparedness paradox
There is no market for sporadic infectious diseases. Even the use of the word ‘market’ is incorrect. ... And we know how to translate academic inventions into medicines that can help patients, but today that’s not happening, because there is no
-
The search for effective drug treatments for COVID-19
medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious ... Diseases’ (NIAID) placebo-controlled phase
-
As COVID-19 takes over the world, biopharma fights back
I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID). ... IL-6 is a type of cytokine that plays an important role in immune response and is
-
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
It is, therefore, critical that action is taken to stop the re-emergence of dangerous infectious diseases.
-
Biotech profile: Tom Evans, CEO, Vaccitech.
He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. ... In 2005, he joined the Novartis Institutes for
More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.
Latest appointments
-
Evoke KYNE promotes Dante DelVecchio to senior VP
In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
-
New faces at HCA, P\S\L Group and Health Unlimited
Over her 15-year career, Peck has worked across a range of healthcare communications areas, including oncology, dermatology, infectious diseases and more.
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
and infectious diseases.
-
Nabriva Therapeutics appoints chief medical officer
Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and
More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.
Latest from PMHub
-
Understanding COVID-19 and varying responses across the globe
The Coalition for Epidemic Preparedness Innovation (CEPI), a global alliance financing and coordinating the development of vaccines against emerging infectious diseases, launched in 2017 and is needed now more than ever. ... These three factors all aid
-
Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar
Professor Jean Paul Stahl, Professor of Infectious Diseases, University Hospital, Grenoble, France. ... Former President of the French Infectious Diseases Society. Edmund Pezalla, Former Vice President, National Medical Director, Pharmaceutical Policy
-
Lucid Group adds more magic to the mix with four new hires
Betty has worked on a wide variety of medical education initiatives in various therapeutic areas including immuno-oncology, infectious diseases, transplantation and multiple sclerosis. ... Katherine has a background in oncology, neurology, metabolic
-
Antibiotic resistance: The silent pandemic
In a globalised world, infectious diseases can travel long distances in relatively short periods of time, making the problem of resistance one that is relevant to all seven billion of us
-
UK vs US: what makes a successful immunisation programme?
Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation programmes ... We understand infectious diseases so well that we
More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Nucleus Global announces a trio of promotions
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer introduces new logo in a ‘shift from commerce to science’
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
